KIR3.4 Antibodies

Santa Cruz Biotechnology features a diverse variety of KIR3.4 monoclonal antibodies for research focused on understanding KIR3.4 protein function. KIR3.4 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).KIR3.4, also known as Killer-cell Immunoglobulin-like Receptor 3.4, is a member of the KIR family, which plays a crucial role in the regulation of immune responses. KIR3.4 is primarily expressed on natural killer (NK) cells and is involved in the recognition of MHC class I molecules, influencing the activation and inhibition of NK cell activity. Understanding KIR3.4 function is essential for elucidating mechanisms of immune evasion by tumors and pathogens, as well as for developing immunotherapeutic strategies.Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of immunology and cancer biology, supporting breakthrough discoveries in the scientific community.